These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28958992)

  • 1. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
    Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
    Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
    Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
    Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
    J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
    Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
    Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
    Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
    Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
    Festuccia C; Mancini A; Colapietro A; Gravina GL; Vitale F; Marampon F; Delle Monache S; Pompili S; Cristiano L; Vetuschi A; Tombolini V; Chen Y; Mehrling T
    J Hematol Oncol; 2018 Feb; 11(1):32. PubMed ID: 29486795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma.
    Lescarbeau RS; Lei L; Bakken KK; Sims PA; Sarkaria JN; Canoll P; White FM
    Mol Cancer Ther; 2016 Jun; 15(6):1332-43. PubMed ID: 27196784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
    Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
    Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.
    Hosein AN; Lim YC; Day B; Stringer B; Rose S; Head R; Cosgrove L; Sminia P; Fay M; Martin JH
    J Neurooncol; 2015 Apr; 122(2):263-71. PubMed ID: 25648357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
    Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT5 as a druggable target for glioblastoma therapy.
    Banasavadi-Siddegowda YK; Welker AM; An M; Yang X; Zhou W; Shi G; Imitola J; Li C; Hsu S; Wang J; Phelps M; Zhang J; Beattie CE; Baiocchi R; Kaur B
    Neuro Oncol; 2018 May; 20(6):753-763. PubMed ID: 29106602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells.
    Merle P; Evrard B; Petitjean A; Lehn JM; Teulade-Fichou MP; Chautard E; De Cian A; Guittat L; Tran PL; Mergny JL; Verrelle P; Tchirkov A
    Mol Cancer Ther; 2011 Oct; 10(10):1784-95. PubMed ID: 21987532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response.
    Chu PM; Chiou SH; Su TL; Lee YJ; Chen LH; Chen YW; Yen SH; Chen MT; Chen MH; Shih YH; Tu PH; Ma HI
    Radiat Oncol; 2011 Jan; 6():7. PubMed ID: 21244709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.
    Jue TR; Nozue K; Lester AJ; Joshi S; Schroder LB; Whittaker SP; Nixdorf S; Rapkins RW; Khasraw M; McDonald KL
    J Transl Med; 2017 Mar; 15(1):61. PubMed ID: 28314386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.